Medytox Appoints Executive Director Choi Seongcheol to Oversee Osong Plant 2 Operations

Former Heads of Hanmi Pharm and GC Green Cross Factories
Osong Plant 2 Pursues cGMP Certification

On the 6th, Medytox announced that it has recruited Executive Director Choi Sung-chul as the head of Osong Plant 2, which is currently pursuing certification for current Good Manufacturing Practice (cGMP) to enter the global market.

Medytox explained that Executive Director Choi Sung-chul is a GMP expert who graduated from Korea University with a degree in Biology and completed his master's and doctoral degrees in Microbiology and Biopharmaceutical Sciences at the same university's graduate school.

Starting with Verna Biotech Korea (formerly Green Cross Vaccine), Executive Director Choi has carried out various projects including the development of recombinant hepatitis B vaccines, construction of a vaccine factory in Vietnam, establishment of a pilot plant in Beijing Hanmi, and founding a corporate bio-process research institute, while working at Hanmi Pharmaceutical and GC Green Cross. Recently, he served as the CEO of CHA BioLab.

Executive Director Choi said, "I am very honored to join Medytox, which possesses the world's best research and development (R&D) capabilities in the field of botulinum toxin," and added, "Based on my extensive experience in bio-process development and production, as well as plant construction management, I will do my best to contribute to Medytox's global expansion."

Meanwhile, Medytox's Osong Plant 2 is a dedicated production facility for the liquid-type botulinum toxin formulation 'MT10109L.' Medytox plans to utilize Osong Plant 2 and Plant 3 as forward bases for global expansion, establishing country-specific overseas entry strategies and proceeding with certification procedures. Based on the results of the Phase 3 clinical trial in the United States, MT10109L aims to apply for approval from the U.S. Food and Drug Administration (FDA) (BLA) within this year.

Choi Sung-chul, Executive Director of Medytox. [Photo by Medytox]

This content was produced with the assistance of AI translation services.